Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2708 | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 3666.0 | 56 | ||||
| RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 174.0 | 43 | |
| RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 1039.0 | 40 | |
| N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 743.0 | 56 | |
| N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 3161.0 | 54 | |
| RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 227.0 | 47 | |
| RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 1383.0 | 51 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6259.0 | 49 | |
| RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6898.0 | 54 | ||||
| N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 7181.0 | 42 | |
| N2645 | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 7411.0 | 51 | ||||
| RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 5863.0 | 41 | |
| RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6011.5 | 52 | ||||
| RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 766.5 | 58 | |
| RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 3081.0 | 44 | |
| N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 1730.0 | 50 | |
| N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 4423.5 | 50 | |
| RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 577.0 | 49 | |
| RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 2580.0 | 53 | |
| RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6643.0 | 53 | |
| RA2159 | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6696.0 | 52 | ||||
| N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 7188.0 | 44 | |
| N2645 | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 8301.0 | 34 | ||||
| RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6913.0 | 43 | |
| RA2708 | TNF-a | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6083.0 | 28 |